How to Choose the Right Probiotic Strain for Your Brand
Strain-level science, clinical evidence and regulatory status — the checklist we walk every partner through before formulation begins.
Not all probiotics are created equal. The species name on the label — Lactobacillus, Bifidobacterium — tells you almost nothing about whether the product will actually work for your customer. It is the strain that carries the clinical evidence, the strain that survives gastric transit, and the strain that determines whether your label claim can survive a regulatory review.
For a brand building or reformulating a probiotic product, choosing the right strains is the single most consequential decision in the entire development process. Get it right and the product earns repeat purchase. Get it wrong and you are left with a shelf-stable powder that does nothing.
Below is the checklist we walk every brand partner through before a single batch is formulated.
1. Match Strains to Your Claims, Not the Other Way Around
The most common mistake brands make is picking popular strains first and then trying to find claims to attach to them. It should work the other way: decide what the product is supposed to do, then find strains with clinical evidence for that specific outcome.
Digestive health: look for strains with published trials on bloating, stool frequency and gut transit time.
Immune support: demand data on upper respiratory tract infection incidence and duration, not generic "supports immunity" language.
Women's health: strains with demonstrated adhesion to vaginal epithelial cells and trials on intimate flora balance.
Children's health: strains with safety and efficacy data in the target age range — a strain proven in adults is not automatically safe or effective in a three-year-old.
Your supplier should be able to show you, strain by strain, the published studies that support your intended claim. If they cannot, keep looking.
2. Demand Strain-Level Identity Data
"Bifidobacterium animalis" is a species. There are hundreds of strains under that species, and their effects are not interchangeable. A supplier selling at the species level is selling you a commodity, not a validated ingredient.
Require the following from every strain you license:
Whole-genome sequencing (WGS) to confirm the strain identity and rule out mislabeled or contaminated cultures.
Strain-specific qPCR assays so that viable counts can be verified at every batch and shelf-life time point.
Species and strain deposition in an internationally recognized culture collection (such as DSM or ATCC).
A complete strain specification sheet including origin, history, safety data and any existing regulatory filings.
At Tingchuang, every strain in our 28+ strain library ships with this documentation as standard. If a supplier resists providing WGS or strain-level traceability, that is a red flag — not a minor omission.
3. Check Regulatory Status Per Market
A strain that is fully approved in the United States may be blocked in the European Union, and a Novel Food authorisation in one member state does not automatically extend to others. Regulatory status is market-specific, and it is the brand's responsibility — not the supplier's — to ensure compliance.
The frameworks you need to understand include:
United States: FDA GRAS (Generally Recognized as Safe) notification or self-affirmed GRAS documentation.
European Union: EFSA QPS (Qualified Presumption of Safety) listing, or a full Novel Food authorisation for strains not yet on the list.
United Kingdom: post-Brexit UK Novel Food process, separate from the EU.
Australia / New Zealand: FSANZ notification and TGA listing depending on the product claim.
China: the strain must be on the published List of Available Strains for Food Use.
Before you commit to a formula, map every target market and confirm each strain's status in each one. A formulation that passes in the US but is blocked in the EU is not a viable global product.
